LYEL · Lyell Immunopharma, Inc. · Analyst Estimates
Market Cap
$298.96M
Shares
24.51M
Analyst Estimates
Compare analyst forecasts for Lyell Immunopharma, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.
Key facts
CIK
1806952
CUSIP
55083R203
13F (30d)
66 filings
65 filers
Visit website
Investor relations